Cargando…

Uncoupling interferons and the interferon signature explain clinical and transcriptional subsets in SLE

Interferons (IFN) are thought to be key players in systemic lupus erythematosus (SLE). The unique and interactive roles of the different IFN families in SLE pathogenesis, however, remain poorly understood. Using reporter cells engineered to precisely quantify IFN-I, IFN-II and IFN-III activity level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Bañuelos, Eduardo, Goldman, Daniel W., Andrade, Victoria, Darrah, Erika, Petri, Michelle, Andrade, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491366/ https://www.ncbi.nlm.nih.gov/pubmed/37693590 http://dx.doi.org/10.1101/2023.08.28.23294734

Ejemplares similares

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases
por: Flint, Shaun M, et al.
Publicado: (2016)

Rheumatoid Arthritis-Associated Mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans
por: Gómez-Bañuelos, Eduardo, et al.
Publicado: (2019)

Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus
por: Gomez-Bañuelos, Eduardo, et al.
Publicado: (2022)

SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature
por: Becker, Amy M., et al.
Publicado: (2013)

Interferon Genes Are Influenced by 17β-Estradiol in SLE
por: Singh, Ram P., et al.
Publicado: (2021)

Cutaneous vasculitis in SLE
por: Kallas, Romy, et al.
Publicado: (2020)

Cause and consequences of the activated type I interferon system in SLE
por: Eloranta, Maija-Leena, et al.
Publicado: (2016)

Interferon pathway in SLE: one key to unlocking the mystery of the disease
por: Rönnblom, Lars, et al.
Publicado: (2019)

Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
por: Oon, Shereen, et al.
Publicado: (2016)

Regulation of B Cell Responses in SLE by Three Classes of Interferons
por: Domeier, Phillip P., et al.
Publicado: (2021)

Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE
por: Kennedy, William P, et al.
Publicado: (2015)

Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients
por: Ko, Kichul, et al.
Publicado: (2013)

Case Report: Response of cutaneous lupus lesions in SLE to interferon receptor blockade parallels reduction of interferon score in blood
por: Günther, Claudia, et al.
Publicado: (2023)

Lymphotoxin-LIGHT Pathway Regulates the Interferon Signature in Rheumatoid Arthritis
por: Bienkowska, Jadwiga, et al.
Publicado: (2014)

Interplay of neutrophils and type I interferons in the development of end-organ damage in SLE
por: Kaplan, MJ
Publicado: (2012)

Loss of antiphospholipid antibody positivity post-thrombosis in SLE
por: Khawaja, Muznay, et al.
Publicado: (2020)

NETs: the missing link between cell death and systemic autoimmune diseases?
por: Darrah, Erika, et al.
Publicado: (2013)

The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE
por: Crawford, Jonathan D., et al.
Publicado: (2023)

DNA-Mediated Interferon Signature Induction by SLE Serum Occurs in Monocytes Through Two Pathways: A Mechanism to Inhibit Both Pathways
por: Porat, Amit, et al.
Publicado: (2018)

An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis
por: Berry, Matthew P. R., et al.
Publicado: (2010)

The effect of prolactin on immune cell subsets involved in SLE pathogenesis
por: Legorreta-Haquet, Maria Victoria, et al.
Publicado: (2022)

Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE
por: Casey, Kerry A, et al.
Publicado: (2018)

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
por: Bennett, Lynda, et al.
Publicado: (2003)

High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry
por: Yiu, Gloria, et al.
Publicado: (2022)

Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus
por: Gomez-Bañuelos, Eduardo, et al.
Publicado: (2023)

Aggregation of MAVS antiviral protein suggests a mechanism for increased type I interferon production in SLE
por: Shao, Wen-Hai, et al.
Publicado: (2014)

Correction: Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE
Publicado: (2018)

Animal Models of Interferon Signature Positive Lupus
por: Zhuang, Haoyang, et al.
Publicado: (2015)

Impaired interferon signature in severe COVID-19
por: Gruber, Conor
Publicado: (2020)

An Interferon-Related Signature in the Transcriptional Core Response of Human Macrophages to Mycobacterium tuberculosis Infection
por: Wu, Kang, et al.
Publicado: (2012)

The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes
por: de Jong, Tamarah D., et al.
Publicado: (2016)

Epigenetic and transcriptional control of interferon-β
por: Daman, Andrew W., et al.
Publicado: (2021)

Associates and predictors of pleurisy or pericarditis in SLE
por: Ryu, Seungwon, et al.
Publicado: (2017)

Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology
por: Reder, Anthony T., et al.
Publicado: (2013)

Evolution of Interferons and Interferon Receptors
por: Secombes, Chris J., et al.
Publicado: (2017)

Uncoupling of the dynamics of host–pathogen interaction uncovers new mechanisms of viral interferon antagonism at the single-cell level
por: Rand, Ulfert, et al.
Publicado: (2014)

Gene Signatures Predict Interferon Response for MS Patients
Publicado: (2005)

An Interferon Signature Discriminates Pneumococcal From Staphylococcal Pneumonia
por: Strehlitz, Anja, et al.
Publicado: (2018)

Distinct interferon signatures stratify inflammatory and dysimmune myopathies
por: Rigolet, Muriel, et al.
Publicado: (2019)

Inflammatory bowel disease pathobiology: the role of the interferon signature
por: Andreou, Nicolaos-Panagiotis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s5fgovguf0nc1shkpj4m183jig